Ionis Pharmaceuticals
IONS
IONS
395 hedge funds and large institutions have $8.14B invested in Ionis Pharmaceuticals in 2019 Q2 according to their latest regulatory filings, with 66 funds opening new positions, 167 increasing their positions, 95 reducing their positions, and 56 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
395
Holders Change
+3
Holders Change %
+0.77%
% of All Funds
8.59%
Holding in Top 10
6
Holding in Top 10 Change
-4
Holding in Top 10 Change %
-40%
% of All Funds
0.13%
New
66
Increased
167
Reduced
95
Closed
56
Calls
$81.3M
Puts
$119M
Net Calls
-$38M
Net Calls Change
+$75.6M
Top Buyers
| 1 |
BG
Bellevue Group
Kuesnacht,
Switzerland
|
+$492M |
| 2 |
Invesco
Atlanta,
Georgia
|
+$141M |
| 3 |
Renaissance Technologies
New York
|
+$113M |
| 4 |
BlackRock
New York
|
+$75.9M |
| 5 |
State Street
Boston,
Massachusetts
|
+$66.4M |
Top Sellers
| 1 |
First Trust Advisors
Wheaton,
Illinois
|
-$58.1M |
| 2 |
T. Rowe Price Associates
Baltimore,
Maryland
|
-$31M |
| 3 |
PP
PDT Partners
New York
|
-$27.7M |
| 4 |
FLAM
First Light Asset Management
Edina,
Minnesota
|
-$18.3M |
| 5 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$14.9M |
